APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cobamamide API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cobamamide API Market Analysis and Forecast 2026-2032

Report ID 173979100223 December 2025190 pages

Choose your research edition.

Industry ResearchCobamamide API Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Cobamamide API Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Cobamamide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cobamamide API Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cobamamide API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Cobamamide API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cobamamide API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cobamamide API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cobamamide API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cobamamide API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Cobamamide API include HTBA, Interquim, Ningxia Kingvit Pharmaceutical, China Pharmaceutical Holding Group and Hebei Yuxing Bio-Engineering, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cobamamide API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cobamamide API, also provides the sales of main regions and countries. Of the upcoming market potential for Cobamamide API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cobamamide API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cobamamide API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cobamamide API sales, projected growth trends, production technology, application and end-user industry.

Cobamamide API Segment by Company

HTBA

Interquim

Ningxia Kingvit Pharmaceutical

China Pharmaceutical Holding Group

Hebei Yuxing Bio-Engineering

Cobamamide API Segment by Type

Purity≥98%

Purity<98%

Cobamamide API Segment by Application

Oral Formulation

Injectable Formulation

Cobamamide API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobamamide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cobamamide API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobamamide API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Cobamamide API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Cobamamide API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cobamamide API sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cobamamide API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity≥98% Major Manufacturers Table 3. Purity<98% Major Manufacturers Table 4. Global Cobamamide API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Oral Formulation Major Manufacturers Table 6. Injectable Formulation Major Manufacturers Table 7. Cobamamide API Industry Trends Table 8. Cobamamide API Industry Drivers Table 9. Cobamamide API Industry Opportunities and Challenges Table 10. Cobamamide API Industry Restraints Table 11. Global Cobamamide API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Cobamamide API Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Cobamamide API Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Cobamamide API Revenue Market Share by Region (2021-2026) Table 15. Global Cobamamide API Revenue Market Share by Region (2027-2032) Table 16. Global Cobamamide API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 17. Global Cobamamide API Sales by Region (2021-2026) & (kg) Table 18. Global Cobamamide API Sales by Region (2027-2032) & (kg) Table 19. Global Cobamamide API Sales Market Share by Region (2021-2026) Table 20. Global Cobamamide API Sales Market Share by Region (2027-2032) Table 21. Global Cobamamide API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Cobamamide API Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Cobamamide API Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Cobamamide API Sales Market Share by Manufacturers (2021-2026) Table 25. Global Cobamamide API Sales Price (USD/kg) of Manufacturers (2021-2026) Table 26. Global Cobamamide API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Cobamamide API Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Cobamamide API Manufacturers, Product Type & Application Table 29. Global Cobamamide API Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Cobamamide API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Cobamamide API Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Cobamamide API Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Cobamamide API Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Cobamamide API Revenue Market Share by Type (2021-2026) Table 36. Global Cobamamide API Revenue Market Share by Type (2027-2032) Table 37. Global Cobamamide API Sales by Type 2021 VS 2025 VS 2032 (kg) Table 38. Global Cobamamide API Sales by Type (2021-2026) & (kg) Table 39. Global Cobamamide API Sales by Type (2027-2032) & (kg) Table 40. Global Cobamamide API Sales Market Share by Type (2021-2026) Table 41. Global Cobamamide API Sales Market Share by Type (2027-2032) Table 42. Global Cobamamide API Price by Type (2021-2026) & (USD/kg) Table 43. Global Cobamamide API Price by Type (2027-2032) & (USD/kg) Table 44. Global Cobamamide API Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Cobamamide API Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Cobamamide API Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Cobamamide API Revenue Market Share by Application (2021-2026) Table 48. Global Cobamamide API Revenue Market Share by Application (2027-2032) Table 49. Global Cobamamide API Sales by Application 2021 VS 2025 VS 2032 (kg) Table 50. Global Cobamamide API Sales by Application (2021-2026) & (kg) Table 51. Global Cobamamide API Sales by Application (2027-2032) & (kg) Table 52. Global Cobamamide API Sales Market Share by Application (2021-2026) Table 53. Global Cobamamide API Sales Market Share by Application (2027-2032) Table 54. Global Cobamamide API Price by Application (2021-2026) & (USD/kg) Table 55. Global Cobamamide API Price by Application (2027-2032) & (USD/kg) Table 56. HTBA Company Information Table 57. HTBA Business Overview Table 58. HTBA Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 59. HTBA Cobamamide API Product Portfolio Table 60. HTBA Recent Development Table 61. Interquim Company Information Table 62. Interquim Business Overview Table 63. Interquim Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 64. Interquim Cobamamide API Product Portfolio Table 65. Interquim Recent Development Table 66. Ningxia Kingvit Pharmaceutical Company Information Table 67. Ningxia Kingvit Pharmaceutical Business Overview Table 68. Ningxia Kingvit Pharmaceutical Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 69. Ningxia Kingvit Pharmaceutical Cobamamide API Product Portfolio Table 70. Ningxia Kingvit Pharmaceutical Recent Development Table 71. China Pharmaceutical Holding Group Company Information Table 72. China Pharmaceutical Holding Group Business Overview Table 73. China Pharmaceutical Holding Group Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. China Pharmaceutical Holding Group Cobamamide API Product Portfolio Table 75. China Pharmaceutical Holding Group Recent Development Table 76. Hebei Yuxing Bio-Engineering Company Information Table 77. Hebei Yuxing Bio-Engineering Business Overview Table 78. Hebei Yuxing Bio-Engineering Cobamamide API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Hebei Yuxing Bio-Engineering Cobamamide API Product Portfolio Table 80. Hebei Yuxing Bio-Engineering Recent Development Table 81. North America Cobamamide API Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Cobamamide API Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Cobamamide API Sales by Type (2021-2026) & (kg) Table 84. North America Cobamamide API Sales by Type (2027-2032) & (kg) Table 85. North America Cobamamide API Sales Price by Type (2021-2026) & (USD/kg) Table 86. North America Cobamamide API Sales Price by Type (2027-2032) & (USD/kg) Table 87. North America Cobamamide API Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Cobamamide API Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Cobamamide API Sales by Application (2021-2026) & (kg) Table 90. North America Cobamamide API Sales by Application (2027-2032) & (kg) Table 91. North America Cobamamide API Sales Price by Application (2021-2026) & (USD/kg) Table 92. North America Cobamamide API Sales Price by Application (2027-2032) & (USD/kg) Table 93. North America Cobamamide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Cobamamide API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Cobamamide API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Cobamamide API Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 97. North America Cobamamide API Sales by Country (2021-2026) & (kg) Table 98. North America Cobamamide API Sales by Country (2027-2032) & (kg) Table 99. North America Cobamamide API Sales Price by Country (2021-2026) & (USD/kg) Table 100. North America Cobamamide API Sales Price by Country (2027-2032) & (USD/kg) Table 101. United States Cobamamide API Revenue (2021-2032) & (US$ Million) Table 102. Canada Cobamamide API Revenue (2021-2032) & (US$ Million) Table 103. Mexico Cobamamide API Revenue (2021-2032) & (US$ Million) Table 104. Europe Cobamamide API Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Cobamamide API Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Cobamamide API Sales by Type (2021-2026) & (kg) Table 107. Europe Cobamamide API Sales by Type (2027-2032) & (kg) Table 108. Europe Cobamamide API Sales Price by Type (2021-2026) & (USD/kg) Table 109. Europe Cobamamide API Sales Price by Type (2027-2032) & (USD/kg) Table 110. Europe Cobamamide API Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Cobamamide API Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Cobamamide API Sales by Application (2021-2026) & (kg) Table 113. Europe Cobamamide API Sales by Application (2027-2032) & (kg) Table 114. Europe Cobamamide API Sales Price by Application (2021-2026) & (USD/kg) Table 115. Europe Cobamamide API Sales Price by Application (2027-2032) & (USD/kg) Table 116. Europe Cobamamide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Cobamamide API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Cobamamide API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Cobamamide API Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 120. Europe Cobamamide API Sales by Country (2021-2026) & (kg) Table 121. Europe Cobamamide API Sales by Country (2027-2032) & (kg) Table 122. Europe Cobamamide API Sales Price by Country (2021-2026) & (USD/kg) Table 123. Europe Cobamamide API Sales Price by Country (2027-2032) & (USD/kg) Table 124. Germany Cobamamide API Revenue (2021-2032) & (US$ Million) Table 125. France Cobamamide API Revenue (2021-2032) & (US$ Million) Table 126. U.K. Cobamamide API Revenue (2021-2032) & (US$ Million) Table 127. Italy Cobamamide API Revenue (2021-2032) & (US$ Million) Table 128. Russia Cobamamide API Revenue (2021-2032) & (US$ Million) Table 129. Spain Cobamamide API Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Cobamamide API Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Cobamamide API Revenue (2021-2032) & (US$ Million) Table 132. Sweden Cobamamide API Revenue (2021-2032) & (US$ Million) Table 133. Poland Cobamamide API Revenue (2021-2032) & (US$ Million) Table 134. China Cobamamide API Revenue by Type (2021-2026) & (US$ Million) Table 135. China Cobamamide API Revenue by Type (2027-2032) & (US$ Million) Table 136. China Cobamamide API Sales by Type (2021-2026) & (kg) Table 137. China Cobamamide API Sales by Type (2027-2032) & (kg) Table 138. China Cobamamide API Sales Price by Type (2021-2026) & (USD/kg) Table 139. China Cobamamide API Sales Price by Type (2027-2032) & (USD/kg) Table 140. China Cobamamide API Revenue by Application (2021-2026) & (US$ Million) Table 141. China Cobamamide API Revenue by Application (2027-2032) & (US$ Million) Table 142. China Cobamamide API Sales by Application (2021-2026) & (kg) Table 143. China Cobamamide API Sales by Application (2027-2032) & (kg) Table 144. China Cobamamide API Sales Price by Application (2021-2026) & (USD/kg) Table 145. China Cobamamide API Sales Price by Application (2027-2032) & (USD/kg) Table 146. Asia Cobamamide API Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Cobamamide API Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Cobamamide API Sales by Type (2021-2026) & (kg) Table 149. Asia Cobamamide API Sales by Type (2027-2032) & (kg) Table 150. Asia Cobamamide API Sales Price by Type (2021-2026) & (USD/kg) Table 151. Asia Cobamamide API Sales Price by Type (2027-2032) & (USD/kg) Table 152. Asia Cobamamide API Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Cobamamide API Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Cobamamide API Sales by Application (2021-2026) & (kg) Table 155. Asia Cobamamide API Sales by Application (2027-2032) & (kg) Table 156. Asia Cobamamide API Sales Price by Application (2021-2026) & (USD/kg) Table 157. Asia Cobamamide API Sales Price by Application (2027-2032) & (USD/kg) Table 158. Asia Cobamamide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Cobamamide API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Cobamamide API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Cobamamide API Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 162. Asia Cobamamide API Sales by Country (2021-2026) & (kg) Table 163. Asia Cobamamide API Sales by Country (2027-2032) & (kg) Table 164. Asia Cobamamide API Sales Price by Country (2021-2026) & (USD/kg) Table 165. Asia Cobamamide API Sales Price by Country (2027-2032) & (USD/kg) Table 166. Japan Cobamamide API Revenue (2021-2032) & (US$ Million) Table 167. South Korea Cobamamide API Revenue (2021-2032) & (US$ Million) Table 168. India Cobamamide API Revenue (2021-2032) & (US$ Million) Table 169. Australia Cobamamide API Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Cobamamide API Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Cobamamide API Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Cobamamide API Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Cobamamide API Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Cobamamide API Sales by Type (2021-2026) & (kg) Table 175. SAMEA Cobamamide API Sales by Type (2027-2032) & (kg) Table 176. SAMEA Cobamamide API Sales Price by Type (2021-2026) & (USD/kg) Table 177. SAMEA Cobamamide API Sales Price by Type (2027-2032) & (USD/kg) Table 178. SAMEA Cobamamide API Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Cobamamide API Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Cobamamide API Sales by Application (2021-2026) & (kg) Table 181. SAMEA Cobamamide API Sales by Application (2027-2032) & (kg) Table 182. SAMEA Cobamamide API Sales Price by Application (2021-2026) & (USD/kg) Table 183. SAMEA Cobamamide API Sales Price by Application (2027-2032) & (USD/kg) Table 184. SAMEA Cobamamide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Cobamamide API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Cobamamide API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Cobamamide API Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 188. SAMEA Cobamamide API Sales by Country (2021-2026) & (kg) Table 189. SAMEA Cobamamide API Sales by Country (2027-2032) & (kg) Table 190. SAMEA Cobamamide API Sales Price by Country (2021-2026) & (USD/kg) Table 191. SAMEA Cobamamide API Sales Price by Country (2027-2032) & (USD/kg) Table 192. Brazil Cobamamide API Revenue (2021-2032) & (US$ Million) Table 193. Argentina Cobamamide API Revenue (2021-2032) & (US$ Million) Table 194. Chile Cobamamide API Revenue (2021-2032) & (US$ Million) Table 195. Colombia Cobamamide API Revenue (2021-2032) & (US$ Million) Table 196. Peru Cobamamide API Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Cobamamide API Revenue (2021-2032) & (US$ Million) Table 198. Israel Cobamamide API Revenue (2021-2032) & (US$ Million) Table 199. UAE Cobamamide API Revenue (2021-2032) & (US$ Million) Table 200. Turkey Cobamamide API Revenue (2021-2032) & (US$ Million) Table 201. Iran Cobamamide API Revenue (2021-2032) & (US$ Million) Table 202. Egypt Cobamamide API Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Cobamamide API Distributors List Table 206. Cobamamide API Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Cobamamide API Image Figure 2. Global Cobamamide API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cobamamide API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Purity≥98% Image Figure 5. Purity<98% Image Figure 6. Global Cobamamide API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cobamamide API Market Size Share 2021 VS 2025 VS 2032 Figure 8. Oral Formulation Image Figure 9. Injectable Formulation Image Figure 10. Global Cobamamide API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Cobamamide API Revenue (2021-2032) & (US$ Million) Figure 12. Global Cobamamide API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Cobamamide API Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Cobamamide API Revenue Market Share by Region (2021-2032) Figure 15. Global Cobamamide API Sales (2021-2032) & (kg) Figure 16. Global Cobamamide API Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 17. Global Cobamamide API Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Cobamamide API Sales YoY (2021-2032) & (kg) Figure 19. Europe Cobamamide API Sales YoY (2021-2032) & (kg) Figure 20. China Cobamamide API Sales YoY (2021-2032) & (kg) Figure 21. Asia (Excluding China) Cobamamide API Sales YoY (2021-2032) & (kg) Figure 22. South America, Middle East and Africa Cobamamide API Sales YoY (2021-2032) & (kg) Figure 23. Global Cobamamide API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Cobamamide API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Cobamamide API Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Cobamamide API Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Cobamamide API Revenue Market Share by Type (2021-2032) Figure 29. Global Cobamamide API Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 30. Global Cobamamide API Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Cobamamide API Sales Market Share by Type (2021-2032) Figure 32. Global Cobamamide API Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Cobamamide API Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Cobamamide API Revenue Market Share by Application (2021-2032) Figure 35. Global Cobamamide API Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 36. Global Cobamamide API Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Cobamamide API Sales Market Share by Application (2021-2032) Figure 38. North America Cobamamide API Revenue Share by Type (2021-2032) Figure 39. North America Cobamamide API Sales Share by Type (2021-2032) Figure 40. North America Cobamamide API Revenue Share by Application (2021-2032) Figure 41. North America Cobamamide API Sales Share by Application (2021-2032) Figure 42. North America Cobamamide API Revenue Share by Country (2021-2032) Figure 43. North America Cobamamide API Sales Share by Country (2021-2032) Figure 44. Europe Cobamamide API Revenue Share by Type (2021-2032) Figure 45. Europe Cobamamide API Sales Share by Type (2021-2032) Figure 46. Europe Cobamamide API Revenue Share by Application (2021-2032) Figure 47. Europe Cobamamide API Sales Share by Application (2021-2032) Figure 48. Europe Cobamamide API Revenue Share by Country (2021-2032) Figure 49. Europe Cobamamide API Sales Share by Country (2021-2032) Figure 50. China Cobamamide API Revenue Share by Type (2021-2032) Figure 51. China Cobamamide API Sales Share by Type (2021-2032) Figure 52. China Cobamamide API Revenue Share by Application (2021-2032) Figure 53. China Cobamamide API Sales Share by Application (2021-2032) Figure 54. Asia Cobamamide API Revenue Share by Type (2021-2032) Figure 55. Asia Cobamamide API Sales Share by Type (2021-2032) Figure 56. Asia Cobamamide API Revenue Share by Application (2021-2032) Figure 57. Asia Cobamamide API Sales Share by Application (2021-2032) Figure 58. Asia Cobamamide API Revenue Share by Country (2021-2032) Figure 59. Asia Cobamamide API Sales Share by Country (2021-2032) Figure 60. SAMEA Cobamamide API Revenue Share by Type (2021-2032) Figure 61. SAMEA Cobamamide API Sales Share by Type (2021-2032) Figure 62. SAMEA Cobamamide API Revenue Share by Application (2021-2032) Figure 63. SAMEA Cobamamide API Sales Share by Application (2021-2032) Figure 64. SAMEA Cobamamide API Revenue Share by Country (2021-2032) Figure 65. SAMEA Cobamamide API Sales Share by Country (2021-2032) Figure 66. Cobamamide API Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Cobamamide API Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥98%
  • Purity<98%
Applications
  • Oral Formulation
  • Injectable Formulation
Companies covered
  • HTBA
  • Interquim
  • Ningxia Kingvit Pharmaceutical
  • China Pharmaceutical Holding Group
  • Hebei Yuxing Bio-Engineering

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cobamamide API Market by Type
  3. 1.2.1 Global Cobamamide API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity≥98%
  5. 1.2.3 Purity<98%
  6. 1.3 Cobamamide API Market by Application
  7. 1.3.1 Global Cobamamide API Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Oral Formulation
  9. 1.3.3 Injectable Formulation
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Cobamamide API Market Dynamics
  1. 2.1 Cobamamide API Industry Trends
  2. 2.2 Cobamamide API Industry Drivers
  3. 2.3 Cobamamide API Industry Opportunities and Challenges
  4. 2.4 Cobamamide API Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Cobamamide API Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Cobamamide API Revenue by Region
  3. 3.2.1 Global Cobamamide API Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cobamamide API Revenue by Region (2021-2026)
  5. 3.2.3 Global Cobamamide API Revenue by Region (2027-2032)
  6. 3.2.4 Global Cobamamide API Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Cobamamide API Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Cobamamide API Sales by Region
  9. 3.4.1 Global Cobamamide API Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Cobamamide API Sales by Region (2021-2026)
  11. 3.4.3 Global Cobamamide API Sales by Region (2027-2032)
  12. 3.4.4 Global Cobamamide API Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Cobamamide API Revenue by Manufacturers
  2. 4.1.1 Global Cobamamide API Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Cobamamide API Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Cobamamide API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cobamamide API Sales by Manufacturers
  6. 4.2.1 Global Cobamamide API Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Cobamamide API Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Cobamamide API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Cobamamide API Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Cobamamide API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Cobamamide API Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Cobamamide API Manufacturers, Product Type & Application
  13. 4.7 Global Cobamamide API Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Cobamamide API Market CR5 and HHI
  16. 4.8.2 2025 Cobamamide API Tier 1, Tier 2, and Tier 3
5 Cobamamide API Market by Type
  1. 5.1 Global Cobamamide API Revenue by Type
  2. 5.1.1 Global Cobamamide API Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Cobamamide API Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Cobamamide API Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Cobamamide API Sales by Type
  6. 5.2.1 Global Cobamamide API Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cobamamide API Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Cobamamide API Sales Market Share by Type (2021-2032)
  9. 5.3 Global Cobamamide API Price by Type
6 Cobamamide API Market by Application
  1. 6.1 Global Cobamamide API Revenue by Application
  2. 6.1.1 Global Cobamamide API Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Cobamamide API Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Cobamamide API Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Cobamamide API Sales by Application
  6. 6.2.1 Global Cobamamide API Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Cobamamide API Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Cobamamide API Sales Market Share by Application (2021-2032)
  9. 6.3 Global Cobamamide API Price by Application
7 Company Profiles
  1. 7.1 HTBA
  2. 7.1.1 HTBA Company Information
  3. 7.1.2 HTBA Business Overview
  4. 7.1.3 HTBA Cobamamide API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 HTBA Cobamamide API Product Portfolio
  6. 7.1.5 HTBA Recent Developments
  7. 7.2 Interquim
  8. 7.2.1 Interquim Company Information
  9. 7.2.2 Interquim Business Overview
  10. 7.2.3 Interquim Cobamamide API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Interquim Cobamamide API Product Portfolio
  12. 7.2.5 Interquim Recent Developments
  13. 7.3 Ningxia Kingvit Pharmaceutical
  14. 7.3.1 Ningxia Kingvit Pharmaceutical Company Information
  15. 7.3.2 Ningxia Kingvit Pharmaceutical Business Overview
  16. 7.3.3 Ningxia Kingvit Pharmaceutical Cobamamide API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ningxia Kingvit Pharmaceutical Cobamamide API Product Portfolio
  18. 7.3.5 Ningxia Kingvit Pharmaceutical Recent Developments
  19. 7.4 China Pharmaceutical Holding Group
  20. 7.4.1 China Pharmaceutical Holding Group Company Information
  21. 7.4.2 China Pharmaceutical Holding Group Business Overview
  22. 7.4.3 China Pharmaceutical Holding Group Cobamamide API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 China Pharmaceutical Holding Group Cobamamide API Product Portfolio
  24. 7.4.5 China Pharmaceutical Holding Group Recent Developments
  25. 7.5 Hebei Yuxing Bio-Engineering
  26. 7.5.1 Hebei Yuxing Bio-Engineering Company Information
  27. 7.5.2 Hebei Yuxing Bio-Engineering Business Overview
  28. 7.5.3 Hebei Yuxing Bio-Engineering Cobamamide API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hebei Yuxing Bio-Engineering Cobamamide API Product Portfolio
  30. 7.5.5 Hebei Yuxing Bio-Engineering Recent Developments
8 North America
  1. 8.1 North America Cobamamide API Market Size by Type
  2. 8.1.1 North America Cobamamide API Revenue by Type (2021-2032)
  3. 8.1.2 North America Cobamamide API Sales by Type (2021-2032)
  4. 8.1.3 North America Cobamamide API Price by Type (2021-2032)
  5. 8.2 North America Cobamamide API Market Size by Application
  6. 8.2.1 North America Cobamamide API Revenue by Application (2021-2032)
  7. 8.2.2 North America Cobamamide API Sales by Application (2021-2032)
  8. 8.2.3 North America Cobamamide API Price by Application (2021-2032)
  9. 8.3 North America Cobamamide API Market Size by Country
  10. 8.3.1 North America Cobamamide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Cobamamide API Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Cobamamide API Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Cobamamide API Market Size by Type
  2. 9.1.1 Europe Cobamamide API Revenue by Type (2021-2032)
  3. 9.1.2 Europe Cobamamide API Sales by Type (2021-2032)
  4. 9.1.3 Europe Cobamamide API Price by Type (2021-2032)
  5. 9.2 Europe Cobamamide API Market Size by Application
  6. 9.2.1 Europe Cobamamide API Revenue by Application (2021-2032)
  7. 9.2.2 Europe Cobamamide API Sales by Application (2021-2032)
  8. 9.2.3 Europe Cobamamide API Price by Application (2021-2032)
  9. 9.3 Europe Cobamamide API Market Size by Country
  10. 9.3.1 Europe Cobamamide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Cobamamide API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Cobamamide API Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Cobamamide API Market Size by Type
  2. 10.1.1 China Cobamamide API Revenue by Type (2021-2032)
  3. 10.1.2 China Cobamamide API Sales by Type (2021-2032)
  4. 10.1.3 China Cobamamide API Price by Type (2021-2032)
  5. 10.2 China Cobamamide API Market Size by Application
  6. 10.2.1 China Cobamamide API Revenue by Application (2021-2032)
  7. 10.2.2 China Cobamamide API Sales by Application (2021-2032)
  8. 10.2.3 China Cobamamide API Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cobamamide API Market Size by Type
  2. 11.1.1 Asia Cobamamide API Revenue by Type (2021-2032)
  3. 11.1.2 Asia Cobamamide API Sales by Type (2021-2032)
  4. 11.1.3 Asia Cobamamide API Price by Type (2021-2032)
  5. 11.2 Asia Cobamamide API Market Size by Application
  6. 11.2.1 Asia Cobamamide API Revenue by Application (2021-2032)
  7. 11.2.2 Asia Cobamamide API Sales by Application (2021-2032)
  8. 11.2.3 Asia Cobamamide API Price by Application (2021-2032)
  9. 11.3 Asia Cobamamide API Market Size by Country
  10. 11.3.1 Asia Cobamamide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Cobamamide API Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Cobamamide API Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cobamamide API Market Size by Type
  2. 12.1.1 SAMEA Cobamamide API Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Cobamamide API Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Cobamamide API Price by Type (2021-2032)
  5. 12.2 SAMEA Cobamamide API Market Size by Application
  6. 12.2.1 SAMEA Cobamamide API Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Cobamamide API Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Cobamamide API Price by Application (2021-2032)
  9. 12.3 SAMEA Cobamamide API Market Size by Country
  10. 12.3.1 SAMEA Cobamamide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Cobamamide API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Cobamamide API Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Cobamamide API Value Chain Analysis
  2. 13.1.1 Cobamamide API Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Cobamamide API Production Mode & Process
  6. 13.2 Cobamamide API Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Cobamamide API Distributors
  9. 13.2.3 Cobamamide API Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst